Key points are not available for this paper at this time.
Abstract Aims Rare studies have investigated the association between heterogeneity of motor progression and risk of early cognitive impairment in Parkinson's disease (PD). In this study, we aim to identify distinct trajectories of motor progression longitudinally and investigate their impact on predicting mild cognitive impairment (MCI). Methods A 5‐year cohort including 415 PD patients at baseline was collected from the Parkinson's Progression Markers Initiative. The severity of motor symptoms was evaluated using the Movement Disorder Society Unified Parkinson's Disease Rating Scale part III. The latent class trajectory model and nonlinear mixed‐effects model were used to analyze and delineate the longitudinal changes in motor symptoms. Propensity score matching (PSM) was used to minimize the impact of potential confounders. Cox proportional hazard models were applied to calculate hazard ratios for MCI, and a Kaplan–Meier curve was generated using the occurrence of MCI during the follow‐up as the time‐to‐event. Results Two latent trajectories were identified: a mild and remitting motor symptoms class (Class 1, 33.01%) and a severe and progressive motor symptom class (Class 2, 66.99%). Patients in Class 2 initially exhibited severe motor symptoms that worsened progressively despite receiving anti‐PD medications. In comparison, patients in Class 1 exhibited milder symptoms that improved following drug therapy and a slower progression. During a 5‐year follow‐up, patients in Class 2 showed a higher risk of developing MCI compared to those in Class 1 before PSM (Log‐Rank 28.58, p < 0.001) and after PSM (Log‐Rank 8.20, p = 0.004). Conclusions PD patients with severe and progressive motor symptoms are more likely to develop MCI than those with mild and stable motor symptoms.
Chen et al. (Thu,) studied this question.